EBITDA Growth
22.30%
Quarterly · Period ending:
SURG EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported22.30%period ending
Latest reported22.30%period ending
SURG Quarterly EBITDA YoY % (81.45% → 22.30%)
Year-over-year change
High-resolution chart · PNG
SURG ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 22.2986% | |
| -51.6473% | |
| 35.7927% | |
| 50.8598% | |
| 34.2868% | |
| -446.254% | |
| -1,786.9182% | |
| -286.7953% | |
| -252.6704% | |
| -58.506% | |
| -71.8481% | |
| 1,124.0787% | |
| 7,649.0218% | |
| 669.6601% | |
| 209.7417% | |
| -245.3166% | |
| -104.1123% | |
| 72.7352% | |
| -184.7968% | |
| 78.5265% | |
| 252.1957% | |
| -42.7022% | |
| 41.0033% | |
| 10.8443% | |
| 43.6349% | |
| -42.5607% | |
| -106.1156% | |
| -245.3378% | |
| -1,765.685% | |
| -487.3376% | |
| -426.6315% | |
| -128.6466% | |
| 84.5955% | |
| 151.9553% | |
| 133.7527% | |
| 63.6498% | |
| -6.5615% | |
| -126.9596% | |
| -37.8972% | |
| -327.0333% | |
| -815.0259% | |
| -608.1691% | |
| -17,283.6874% | |
| -982.2099% | |
| -622.8244% | |
| 128.9637% | |
| 77.6608% | |
| -11.6923% | |
| 36.5855% | |
| 2,386.7534% | |
| -393.432% | |
| 42.4191% | |
| -178.3451% | |
| 97.6927% | |
| 98.9517% | |
| 90.5497% | |
| 93.4998% | |
| -4.0746% | |
| -359.9865% | |
| -39.3557% | |
| 29.112% | |
| 85.7549% | |
| 50.2203% | |
| 42.0413% | |
| 6.8642% | |
| 28.5083% | |
| 66.2144% | |
| -124.4333% | |
| -3,717.8846% | |
| -40,189.7098% | |
| -254.1913% | |
| 77.9696% | |
| 81.4488% |